We Care 4 'all' / SHE

Wegovy Injections vs. Roux-en-Y Bypass Surgery – What’s Better for Long-Term Weight and Health Management? If you’re dealing with obesity, you probably also face complications like PCOD, infertility, diabetes, joint pain, or sleep apnea. With Wegovy (a GLP-1 analogue) recently launched in India, many wonder — should I go for this "miracle" drug, or consider bariatric/metabolic surgery? Let’s compare them in terms of cost, effectiveness, safety, and long-term impact — especially in the Indian context. What Are You Really Looking For? Ask yourself: 👉 Do I want permanent weight loss or temporary relief? 👉 Do I want to address infertility, insulin resistance, hormonal imbalance, or just drop kilos? 👉 Can I afford a lifelong injection plan? These questions help you choose between: GLP-1 agonist drugs like Wegovy & Permanent solutions like Roux-en-Y Gastric Bypass 💉 Wegovy: What You Need to Know Wegovy (semaglutide) is a GLP-1 receptor agonist initially approved for type 2 ...

PCOD, Obesity & Infertility – Understanding the Link Polycystic Ovarian Disease (PCOD) is often aggravated by obesity, leading to hormonal imbalances, insulin resistance, and infertility. Bariatric surgeries have emerged as powerful tools for weight reduction, hormonal regulation, and fertility restoration in obese women with PCOD. Among the surgical options, Sleeve Gastrectomy (SG) and Roux-en-Y Gastric Bypass (RYGB) are most popular.  But which one works best for fertility? ⚖️ Sleeve Gastrectomy vs Roux-en-Y Bypass: Key Differences Mechanism:  Sleeve Gastrectomy (SG): Restrictive (reduces stomach size) Roux-en-Y Gastric Bypass (RYGB): Restrictive + Malabsorptive Hormonal Changes : Sleeve Gastrectomy (SG): Lower ghrelin (hunger hormone) Roux-en-Y Gastric Bypass (RYGB): Strong insulin, GLP-1 effect Weight Loss:  Sleeve Gastrectomy (SG): 50–60% of excess weight Roux-en-Y Gastric Bypass (RYGB): 60–80% of excess weight Insulin Resistance:  Sleeve Gastrectomy (S...